Daily Bulletin

Men's Weekly

.

Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA Nephropathy (IgAN) and Complement 3 Glomerulopathy (C3G) in China and Australia

CAMBRIDGE, Mass., Dec. 20, 2022 /PRNewswire/ -- Kira Pharmaceuticals, a global biotechnology company pioneering transformational complement therapies to treat immune-mediated diseases, announced today that the Chinese National Medical Products Administration (NMPA) and the Australian Therapeutic Goods Administration (TGA) have approved...

Read more: Kira Pharmaceuticals Announces Clearance to Initiate Phase 2 Evaluation of KP104 in IgA...

Business News

Tuning Strategies for Modern Trucks: Putting SCT X4 Performance to the Test

The Case for Aftermarket Tuning in Modern Trucks Factory programmers aren't trying to thrill you. They’re chasing emissions compliance, warranty safety nets, and broad market compatibility. That co...

Daily Bulletin - avatar Daily Bulletin

Automotive Expert, Raffy Sgroi, Warns: Australia is Building Snowflakes in the Desert with EV Policy

With the National Electric Vehicle Strategy due for a comprehensive review during 2026, automotive expert and senior government advisor, Raffy Sgroi, warns that Australia is rushing electric vehic...

Daily Bulletin - avatar Daily Bulletin

China Gold Coin Group Launched 2026 Chinese Dragon Silver Bullion Coin at World Money Fair in Berlin

China Gold Coin Group Co., Ltd. unveiled its 2026 Chinese Dragon Silver Bullion Coin at the World Money Fair held in Berlin, Germany, from January 29 to 31. Led by Mr Jinpu Jiao, Chairman of the Boa...

Daily Bulletin - avatar Daily Bulletin

Speed Dating For Business